Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1383 results for "pharma"

Alembic Pharma jumps on strong Q2 result

Alembic Pharmaceuticals , a vertically integrated research and development pharmaceutical company, witnessed a rise in share price on Monday after it disclosed a good increase in consolidated net profit for the quarter ended September 2014. During the ... Myiris, 2 hours ago

4,005 images for pharma

Financial Director, 3 hours ago
Mubasher, 23 hours ago
RTTNews.com, 37 minutes ago
American Banking News, 2 days ago
Sify, 2 days ago
American Banking News, 4 days ago
One News Page United Kingdom, 2 days ago
APN News, 3 days ago
BusinessWeek, 9 hours ago
Pharma Letter, 22 hours ago
Proactive Investors USA

Update: Horizon Pharma Acquires U.S. Rights For Pennsaid 2%, Long Case Strengthens

Summary Horizon Pharma acquired the U.S. rights to Nuvo Research's Pennsaid 2% for the treatment of pain due to osteoarthritis of the knee for $45 million in cash. Pennsaid 2% was approved in January 2014 and had an annualized revenue run rate of ...
 Seeking Alpha1 day ago Horizon Pharma buys US rights to Nuvo's Pennsaid for $45 million  Pharma Letter22 hours ago Horizon Pharma Plc (HZNP) Jumps 5.32% on October 17  Equities.com2 days ago Horizon Pharma Picks Up Nuvo's Osteoarthritis Pain Drug for $45M  Genetic Engineering News2 days ago
[x]  

Alembic Pharma Q2 Profit Up 25 Per Cent at Rs 77.27 Crore

New Delhi : Alembic Pharmaceuticals on Monday reported a 25.35 per cent rise in consolidated net profit after tax and share of profit of associates to Rs 77.27 crore for the second quarter that ended on September 30, 2014-15, mainly on account of ...
 NDTV Profit3 hours ago Alembic Pharma net profit surges by 25 % in Q2  PharmaBiz4 hours ago Alembic Pharma Q2 up 25% at Rs 77.27 cr  Business Standard4 hours ago Alembic Pharma Q2 net profit at Rs772.70 mn  India Infoline4 hours ago
[x]  
Rediff.com

IT firms put up a poor show in Q2, all eyes now on auto, pharma

The second-quarter results of companies that have declared results so far seem to confirm the current fragility on Dalal Street. Reason: An unsatisfactory show by information technology services companies and Reliance Industries. The early birds indicate a sharp slowdown in revenue growth and tepid profit growth despite gains from lower raw material costs, employee and depreciation allowances. The combined revenues of 108 companies were up 3.2 per cent year-on-year in the second quarter, ...
 Rediff.com5 hours ago Aurobindo Pharma's Q2 results on November 06, 2014  Money Control8 hours ago Ajanta Pharma's Q2 results on Oct 30, 2014  Money Control4 days ago

Alembic Pharma expects API biz to grow 10% in FY15

The growth for the international generics, however, remain muted at about 9 percent due to higher base last year.
 Money Control3 hours ago
Rediff.com

Ranbaxy staff get pay-cut shield in Sun buyout

The agreement agreed to by Sun Pharmaceutical Industries for a buyout of Ranbaxy Laboratories from Daiichi Sankyo provides for a year's 'cooling period' during which the pay of Ranbaxy employees cannot be lowered, it is learnt. Ranbaxy is said to have also budgeted around Rs 65 crore for a retention bonus and identified 70-75 executives to distribute this. The year's cooling period is expected to start from the completion of the transaction between Sun and Daiichi, a source said. Ranbaxy ...
 Rediff.com6 hours ago Canadian Competition Bureau provides preliminary guidance on pharma patent settlements  Lexology3 days ago Ranbaxy Labs gains 1% on litigation settlement with Texas  Money Control4 days ago Ranbaxy to pay USD 39.75 million for litigation settlement with Texas  Jagran Post4 days ago

Sell Adani Ports; buy Arvind, RComm: Vishal Malkan

Vishal B Malkan of malkansview.com recommends buying Reliance Communications with a target of Rs 106 and Aurobindo Pharma with a target of Rs 950.
 Money Control6 hours ago Bull's Eye: Buy Glenmark, HPCL, Sintex, IndusInd Bank  Money Control4 days ago Bull's Eye: Buy Reliance Cap, Ashok Leyland, Shasun Pharma  Money Control6 days ago Bull's Eye: Buy Biocon, India Cements, Aurobindo Pharma  Money Control4 weeks ago
Bio Spectrum Asia

Fosun Pharma to invest in Israel's Check-Cap

 Bio Spectrum Asia7 hours ago Fosun Pharma To Invest In Check-Cap  BioSpace1 day ago GIM: MP racks up investments of Rs 6.89 lakh cr  Deccan Herald6 days ago Investment commitments decline in Gujarat in last 3 years  Rediff.com4 weeks ago
[x]  

Q2 Result Preview: Alembic Pharma, Exide Inds, Swaraj Engines

Following are the Q2 earnings preview from Angel Broking for companies whose results are expected today: Alembic Pharma ''For the quarter, the company is expected to post sales and net profit of Rs 5.68 billion and Rs 808 million, registering a ...
 MyIris8 hours ago

To maintain 25-30% margin; bullish on pharma, IT: Edelweiss

Rashesh Shah also expects private banks and manufacturing companies to come back into the portfolio.
 Money Control8 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pharma
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less